Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

Ceprotin Treatment Registry

ClinicalTrials.gov ID: NCT01127529

Public ClinicalTrials.gov record NCT01127529. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 16, 2026, 11:38 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The overall objective is to collect and assess data on the treatment, safety, and treatment outcomes of subjects prescribed, receiving and participating in the Ceprotin treatment registry.

Study identification

NCT ID
NCT01127529
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Baxalta now part of Shire
Industry
Enrollment
43 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 23, 2010 (Actual)
Primary completion
Jun 22, 2015 (Actual)
Completion
Jun 22, 2015 (Actual)
Last update posted
Mar 17, 2021

2010 – 2015

United States locations

U.S. sites
12
U.S. states
9
U.S. cities
12
Facility City State ZIP Site status
Not listed Phoenix Arizona — —
Not listed Orange California — —
Not listed Aurora Colorado — —
Not listed Indianapolis Indiana — —
Not listed Boston Massachusetts — —
Not listed Grand Rapids Michigan — —
Not listed Lebanon New Hampshire — —
Not listed Cincinnati Ohio — —
Not listed Columbus Ohio — —
Not listed Dayton Ohio — —
Not listed Fort Worth Texas — —
Not listed Houston Texas — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01127529, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 17, 2021 · Synced Oct 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01127529 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →